Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Meheco Co., Ltd. is a prominent state-owned pharmaceutical enterprise in China, functioning as a core subsidiary of the China General Technology (Group) Holding Co., Ltd. (Genertec). The company is a comprehensive healthcare provider with a business model spanning the entire industry chain, including the cultivation of medicinal herbs, pharmaceutical R&D, manufacturing, and international trade. Historically, it served as the primary national gateway for the export of Traditional Chinese Medicines (TCM), specifically through its 'Chinese Patent Medicines & Medicated Liquors' business line. Today, China Meheco is a major player in the distribution of both domestic and imported pharmaceuticals and medical equipment, and it maintains significant manufacturing capabilities for active pharmaceutical ingredients (APIs) and finished dosage forms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chinese Patent Medicines & Medicated Liquors.